Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oasmia Pharmaceutical AB (NASDAQ:OASM)

2.09
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
1.39
Today|||52-Week Range
5.15
-25.58%
Year-to-Date
No recent news for Oasmia Pharmaceutical AB.

Today’s Trading

Previous close2.09
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)11,609
Market cap$74.7M
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)+3.40%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+173.88%
P/E ratio--
Price/Sales210.89
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.04-0.11%
TEVATeva Pharmaceutical-0.21-0.73%
Data as of 4:02pm ET, 05/26/2017

Financials

Last reporting dateDecember 2, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$755.9K
Annual profit (last year)-$16.8M
Net profit margin-2,220.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Mikael Asp
Chief Operating Officer
Amir Tatarevic
Corporate headquarters
Uppsala, Uppsala

Forecasts

Chart unavailable